Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Treatment and Prevention Strategies

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Russia’s Takeover Of Crimea Negatively Impacting HIV Prevention Services

The Independent: Battling AIDS: Former health secretary claims Russia is causing setback in efforts to defeat the virus Norman Fowler, former British health secretary “…One of the unwelcome first results of the Russian takeover of Crimea has been a radical change in policy on the treatment of injecting drug users.…

Some Countries Win Lower Pricing For Hepatitis C Treatment; Pharma Defends High Cost

News outlets report on developments surrounding the pricing of Gilead’s hepatitis C treatment, Sovaldi. Bloomberg News: Developing Countries Pay 1% of U.S. Price for Gilead’s Sovaldi “Developing countries such as Egypt, India, and Brazil won discounts to pay one percent of the $84,000 price Gilead Sciences Inc. is charging U.S.…

Learning From HIV To Treat, Prevent HPV, Other Cancers

The Hill: HPV may be the new HIV Elizabeth Chabner Thompson, founder of BFFL Co. “In May, I will be traveling with a group of physicians to Botswana for a conference sponsored by the Ministry of Health and several other organizations in hopes to inspire discussion around cancer care in…

Working Together, Global Community Can Defeat Vector-Borne Diseases

Katherine Bliss, senior associate at the Global Health Policy Center of the Center for Strategic and International Studies (CSIS), writes in the center’s “Smart Global Health” blog about this year’s World Health Day, the theme of which was “preventing vector-borne diseases.” She writes, “With more than one billion people globally…

WHO Releases Hepatitis C Treatment Guidelines Amid Calls For Lower Cost Treatment

Media sources report on the WHO’s first-ever hepatitis C treatment guidelines and increased efforts to lower the cost of the most effective treatments. Financial Times: Price of hepatitis C drug attacked “Gilead Sciences is facing mounting pressure over its new $1,000-a-day hepatitis C drug after the World Health Organization joined…

Al Jazeera’s ‘Lifelines’ Series Posts New Content

Al Jazeera: Lifelines: The Quest for Global Health The news service posts new information in its “Lifelines” series, including pages focused on rabies, river blindness, trachoma, malaria, and schistosomiasis (4/10).

Ebola Outbreak In West Africa Is ‘Challenging,’ Expected To Last Months, WHO Says

News outlets report on the spread of an Ebola outbreak that continues to claim lives in West Africa. Agence France-Presse: West Africa Ebola outbreak among ‘most challenging’ ever: WHO “West Africa’s Ebola unprecedented outbreak is among the ‘most challenging’ for health workers since the deadly disease emerged elsewhere in Africa…

Efforts Underway To Lower Cost Of New Hepatitis C Drug

Two Reuters articles discuss efforts to lower the cost of a new hepatitis C treatment. Reuters: Gilead aims to license hepatitis C drug to 3-4 Indian firms “Gilead Sciences aims to license its new hepatitis C drug Sovaldi to three or four Indian generic manufacturers to allow sales of the…

India Marks 10 Years Of Cost-Free ART Program

LiveMint: Govt HIV treatment program completes 10 years “India completed 10 years of the free antiretroviral treatment (ART) program for human immunodeficiency virus (HIV) patients, now covering 768,000 people. While the first HIV case in India was detected in 1986, about 2.1 million Indians are now living with the AIDS…

Study, Commentary Examine XDR-TB Treatment Outcomes In S. Africa

A post in the Center for Global Health Policy’s “Science Speaks” blog discusses a study and commentary published last week in The Lancet that evaluated the long-term outcomes of extensively drug-resistant tuberculosis (XDR-TB) patients in South Africa. “…Both the report and commentary call for policymakers and national control programs to…